In breast cancer also, the TF/FVIIa-mediated activation of PAR2 is shown to promote cancer invasiveness via the AKT/GSK3β-driven nuclear accumulation of β-catenin and the induction of EMT [84]. Here, F2RL1 is linked to cancer.